Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice.
Cancers (Basel). 2022 Jan 29;14(3):691. doi: 10.3390/cancers14030691.
Cancers (Basel). 2022.
PMID: 35158960
Free PMC article.
Review.
Hypermucoviscous Klebsiella pneumoniae: A Hypervirulent Strain Masquerading as Metastasis.
Ombada M, Perwez T, Campitelli M, Zeineddine N.
Ombada M, et al.
Cureus. 2023 May 27;15(5):e39561. doi: 10.7759/cureus.39561. eCollection 2023 May.
Cureus. 2023.
PMID: 37378155
Free PMC article.
Item in Clipboard
Piperacillin/Tazobactam and Meropenem Use Increases the Risks for Acute Graft Rejection Following First Kidney Transplantation.
Nasr D, Moein M, Niforatos S, Nasr S, Ombada M, Khokhar F, Shahnawaz M, Poudyal B, Bou Zerdan M, Dutta D, Saidi RF, Lim SH.
Nasr D, et al. Among authors: ombada m.
J Clin Med. 2022 May 11;11(10):2726. doi: 10.3390/jcm11102726.
J Clin Med. 2022.
PMID: 35628853
Free PMC article.
Item in Clipboard
Liposomal Daunorubicin and Cytarabine, a Potential Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Ashok Kumar P, Ombada M, Pemmasani G, Tambe A, Banki K, Gentile T.
Ashok Kumar P, et al. Among authors: ombada m.
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221127114. doi: 10.1177/23247096221127114.
J Investig Med High Impact Case Rep. 2022.
PMID: 36341907
Free PMC article.
Item in Clipboard
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer.
Bou Zerdan M, Ashok Kumar P, Barrios DM, Glidden A, Nasr D, Niforatos S, Ghelani G, Leibovitch J, Nasr S, Kc B, Ombada M, Khokhar F, Poudyal B, Bhandari J, Shahnawaz M, Graziano S, Lim SH.
Bou Zerdan M, et al. Among authors: ombada m.
Front Oncol. 2023 May 12;13:1134824. doi: 10.3389/fonc.2023.1134824. eCollection 2023.
Front Oncol. 2023.
PMID: 37251929
Free PMC article.
Item in Clipboard
Cite
Cite